Please try another search
For the fiscal year ended 31 December 2019, Kainos Medicine Inc revenues was not reported. Net loss remained flat at W7.94B. Net income also reflects R & D Expense - Balancing value decrease of 16% to W4.81B (expense), Amort of Intangibles decrease of 37% to W94.3M (expense), Rental Expense decrease of 64% to W25.9M (expense), offset by Stock-Based Compensation increase from W232.2M to W605.7M (expense).
Period Ending: | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 2178.6 | 2160.03 |
Gross Profit | 0 | 0 | 1968.66 | 2084.93 |
Operating Income | -7990.77 | -7634.01 | -2422.21 | -2574.06 |
Net Income | -7935.69 | -7944.34 | -2623.8 | -2496.93 |
Period Ending: | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Total Assets | 5498.35 | 8189.38 | 7587.37 | 1218.64 |
Total Liabilities | 506.98 | 169.88 | 1439.07 | 1518.21 |
Total Equity | 4991.37 | 8019.51 | 6148.29 | -299.57 |
Period Ending: | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
---|---|---|---|---|
Period Length: | 12 Months | 12 Months | 12 Months | 12 Months |
Cash From Operating Activities | -6947.28 | -5250.71 | -4006.54 | -2363.12 |
Cash From Investing Activities | 2851.81 | -3750.76 | -244.21 | -113.27 |
Cash From Financing Activities | 4133.64 | 8305.65 | 8416.58 | 746.22 |
Net Change in Cash | 37.3 | -692.63 | 4162.71 | -1728.28 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review